Melanoma of unknown primary origin metastasizing to the ovary and breast: Case report and review of literature

S. Niu, L. Li, Y. Peng
{"title":"Melanoma of unknown primary origin metastasizing to the ovary and breast: Case report and review of literature","authors":"S. Niu, L. Li, Y. Peng","doi":"10.14312/2397-6845.2019-1","DOIUrl":null,"url":null,"abstract":"Malignant melanoma (MM) simultaneously involving the ovary and breast is a rare manifestation of the disease. We report a case of amelanotic MM of unknown primary origin manifesting as a large ovarian solid mass at its first clinical presentation. A 46-year-old woman presented with a two week history of lower abdominal pain. Imaging studies revealed an 18 cm right ovarian mass and a 1.1 cm left breast mass. The ovarian mass was first removed and it showed smooth capsule. Histologically, the tumor exhibited predominantly solid and nested growth patterns with scattered follicle-like spaces. The cells had large atypical nuclei with prominent nucleoli, and brisk mitotic activity. No melanin pigment was identified. No evidence of mature teratoma in the ovary was found. Immunohistochemically, the tumor was diffusely positive for SOX10, S-100, HMB-45, Melan-A and WT-1, and negative for cytokeratins, PAX-8, ER, PR, CD45, SALL4, and inhibin. Biopsy of the breast lesion showed a poorly differentiated malignancy with identical morphology. A diagnosis of metastatic melanoma to the ovary and breast was established. Thorough physical examination and imaging study revealed no evidence of cutaneous, uveal, or mucosal lesions. Probably, a primary MM was occult or had regressed. Subsequent molecular test for BRAF V600E mutation in the tumor was positive. The patient rapidly developed widespread metastasis. Immunotherapy was initiated; she had excellent response with significant tumor regression at her six month follow up visit. This case represents an example that making correct and timely diagnosis of metastatic melanoma followed by prompt targeted therapy significantly improved the patient’s clinical outcome.","PeriodicalId":358125,"journal":{"name":"Journal of Modern Human Pathology","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Modern Human Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14312/2397-6845.2019-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Malignant melanoma (MM) simultaneously involving the ovary and breast is a rare manifestation of the disease. We report a case of amelanotic MM of unknown primary origin manifesting as a large ovarian solid mass at its first clinical presentation. A 46-year-old woman presented with a two week history of lower abdominal pain. Imaging studies revealed an 18 cm right ovarian mass and a 1.1 cm left breast mass. The ovarian mass was first removed and it showed smooth capsule. Histologically, the tumor exhibited predominantly solid and nested growth patterns with scattered follicle-like spaces. The cells had large atypical nuclei with prominent nucleoli, and brisk mitotic activity. No melanin pigment was identified. No evidence of mature teratoma in the ovary was found. Immunohistochemically, the tumor was diffusely positive for SOX10, S-100, HMB-45, Melan-A and WT-1, and negative for cytokeratins, PAX-8, ER, PR, CD45, SALL4, and inhibin. Biopsy of the breast lesion showed a poorly differentiated malignancy with identical morphology. A diagnosis of metastatic melanoma to the ovary and breast was established. Thorough physical examination and imaging study revealed no evidence of cutaneous, uveal, or mucosal lesions. Probably, a primary MM was occult or had regressed. Subsequent molecular test for BRAF V600E mutation in the tumor was positive. The patient rapidly developed widespread metastasis. Immunotherapy was initiated; she had excellent response with significant tumor regression at her six month follow up visit. This case represents an example that making correct and timely diagnosis of metastatic melanoma followed by prompt targeted therapy significantly improved the patient’s clinical outcome.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
原发来源不明的黑色素瘤转移至卵巢及乳房:病例报告及文献回顾
恶性黑色素瘤(MM)同时累及卵巢和乳房是一种罕见的表现的疾病。我们报告一例原发性不明的无色性MM,在其首次临床表现为一个大的卵巢实性肿块。一名46岁女性,有两周的下腹部疼痛史。影像学检查显示右侧卵巢肿块18厘米,左侧乳房肿块1.1厘米。首先切除卵巢肿块,肿块呈光滑的囊状。组织学上,肿瘤主要表现为实性和巢状生长模式,伴有分散的滤泡样间隙。非典型细胞核大,核仁突出,有丝分裂活跃。未发现黑色素。卵巢未发现成熟畸胎瘤。免疫组化结果显示,肿瘤弥漫性SOX10、S-100、HMB-45、Melan-A和WT-1阳性,细胞角蛋白、PAX-8、ER、PR、CD45、SALL4和抑制素阴性。乳腺病变活检显示为形态相同的低分化恶性肿瘤。诊断为卵巢和乳房转移性黑色素瘤。彻底的体格检查和影像学检查未发现皮肤、葡萄膜或粘膜病变的证据。原发性MM可能是隐匿的或已退化。随后的分子检测肿瘤中BRAF V600E突变呈阳性。病人迅速发生了广泛的转移。开始免疫治疗;在她6个月的随访中,她的肿瘤消退明显。该病例表明,对转移性黑色素瘤做出正确及时的诊断,并及时进行靶向治疗,显著改善了患者的临床预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Squamous cell carcinoma in situ of the endometrium - A case report with review of the literature Melanoma of unknown primary origin metastasizing to the ovary and breast: Case report and review of literature Metastatic epithelioid hemangioendothelioma to the bone marrow with associated myelofibrosis resembling primary myelofibrosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1